Menu
1-702-720-6310 info@microcapspecualtors.com

Neurimmune, TVM setup ALS biotech, secure support of Eli Lilly unit for advance toward clinical proof of concept – FierceBiotech


FierceBiotech

Neurimmune, TVM setup ALS biotech, secure support of Eli Lilly unit for advance toward clinical proof of concept
FierceBiotech
Neurimmune and TVM Capital Life Science have partnered to create and fund a single-asset biotech focused on amyotrophic lateral sclerosis (ALS). The biotech, AL-S Pharma, plans to work with Eli Lilly unit Chorus to take a human monoclonal antibody …

and more »

Search